Author

Xiong-Fei Xu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

The miR-6538 in extracellular vesicles derived from lycorine-pretreated mesenchymal stem cells enhances therapeutic efficacy in rheumatoid arthritis.

Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) were engineered as a targeted platform for Lycorine (LYC), a natural isoquinoline alkaloid with anti-inflammatory and anti-neoplastic properties that exhibits therapeutic potential in inflammatory diseases but is limited by systemic toxicity in clinical app...

Wu-Yan Zheng, Xiong-Fei Xu, Chen-Xu Yang et al. · Biomaterials · 0 citations

Review Open access Aug 2026

Evolving role of Anti-CD20 monoclonal antibodies in rheumatoid arthritis: efficacy, safety, economic perspectives, and future directions—a narrative review

B-cell depletion has established an important therapeutic role in rheumatoid arthritis (RA), particularly in selected patients with an inadequate response to tumor necrosis factor inhibitors or with clinical features favoring rituximab. However, the optimal positioning of anti-CD20 therapy remains constrained by...

Yang Cao, Xiong-Fei Xu, Ning Ma et al. · BMC Medicine · 0 citations